Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

444 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Orally administrated acetate inhibits atherosclerosis progression through AMPK activation via GPR43 in plaque macrophages.
Wada T, Senokuchi T, Shi Y, Furusho T, Morita Y, Sarie M, Hanatani S, Fukuda K, Ishii N, Matsumura T, Fujiwara Y, Komohara Y, Araki E, Kubota N. Wada T, et al. Among authors: araki e. Atherosclerosis. 2024 Dec 12;401:119088. doi: 10.1016/j.atherosclerosis.2024.119088. Online ahead of print. Atherosclerosis. 2024. PMID: 39705906 Free article.
Efficacy and Safety of Pemafibrate Extended-Release Tablet: a Phase 3, Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel-Group Comparison Trial.
Arai H, Yamashita S, Araki E, Yokote K, Tanigawa R, Saito A, Yamasaki S, Suganami H, Ishibashi S. Arai H, et al. Among authors: araki e. J Atheroscler Thromb. 2024 Nov 1;31(11):1517-1538. doi: 10.5551/jat.64677. Epub 2024 Apr 13. J Atheroscler Thromb. 2024. PMID: 38616112 Free PMC article. Clinical Trial.
Clinical Pharmacology of Pemafibrate Extended-release Formulation in Patients with Hypertriglyceridemia-A Phase 2, Multicenter, Active-controlled, Randomized, Single-blind, Crossover study.
Yamashita S, Araki E, Arai H, Yokote K, Tanigawa R, Saito A, Suganami H, Minamikawa S, Ishibashi S. Yamashita S, et al. Among authors: araki e. J Atheroscler Thromb. 2024 Sep 26. doi: 10.5551/jat.65001. Online ahead of print. J Atheroscler Thromb. 2024. PMID: 39322570 Free article.
Causes of death in Japanese patients with diabetes based on the results of a survey of 68,555 cases during 2011-2020: Committee report on causes of death in diabetes mellitus, Japan Diabetes Society (English version).
Nakamura J, Yoshioka N, Katagiri H, Ueki K, Yamauchi T, Inagaki N, Tanizawa Y, Araki E, Nakayama T, Kamiya H. Nakamura J, et al. Among authors: araki e. J Diabetes Investig. 2024 Dec;15(12):1821-1837. doi: 10.1111/jdi.14232. Epub 2024 Oct 4. J Diabetes Investig. 2024. PMID: 39363847 Free PMC article.
Causes of death in Japanese patients with diabetes based on the results of survey of 68,555 cases during 2011-2020: committee report on causes of death in diabetes mellitus, Japan Diabetes Society (English version).
Nakamura J, Yoshioka N, Katagiri H, Ueki K, Yamauchi T, Inagaki N, Tanizawa Y, Araki E, Nakayama T, Kamiya H. Nakamura J, et al. Among authors: araki e. Diabetol Int. 2024 Oct 4;15(4):641-665. doi: 10.1007/s13340-024-00736-3. eCollection 2024 Oct. Diabetol Int. 2024. PMID: 39469561
444 results